Sanofi (SNY) earnings: date, estimates, results and stock reactions
Next earnings: Q1 FY2027 on 2027-01-28 (expected, time not announced). EPS estimate 1.71, revenue estimate 12.91B.
Over the last 12 reports the stock moved 3.7% on average (either way), rising 7 times and falling 5. EPS beat estimates 8 of 12 times; revenue 9 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q4 FY2026 | 2026-10-30 | 2.52 | 1.80 | +40.0% | 15.23B | 12.81B | +5.9% |
| Q3 FY2026 | 2026-07-30 | 2.09 | 1.90 | +10.0% | 12.30B | 13.30B | -6.8% |
| Q2 FY2026 | 2026-04-23 | 1.34 | 1.90 | -29.5% | 11.24B | 10.90B | -0.9% |
| Q1 FY2026 | 2026-01-29 | 1.66 | 1.81 | -8.3% | 23.74B | 9.88B | +2.1% |
| Q4 FY2025 | 2025-10-24 | 2.27 | 1.46 | +55.5% | 13.17B | 11.10B | +1.8% |
| Q3 FY2025 | 2025-07-31 | 3.20 | 2.92 | +9.6% | 10.74B | 12.36B | -6.1% |
| Q2 FY2025 | 2025-04-24 | 1.79 | 1.67 | +7.2% | 10.61B | 10.00B | -0.9% |
| Q1 FY2025 | 2025-01-30 | 1.31 | 1.65 | -20.6% | 7.63B | 9.51B | +2.5% |